EDITORIAL ARTICLE
Situation of rheumatology in Poland in 2012
More details
Hide details
Online publication date: 2012-09-07
Reumatologia 2012;50(4):263-275
KEYWORDS
ABSTRACT
In this work we discuss issues covering various aspects of the health care system of patients with rheumatic diseases in Poland: education and training in rheumatology, health services utilization (ambulatory and inpatient care) and access to biological treatment of rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis. In Poland compared to other Central European countries the restrictions resulting from therapeutic programs may influence lower usage of biologics.
REFERENCES (13)
1.
Smolen JS, Landewe R, Breedveld FC, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs. Ann Rheum Dis 2010;69:964-975.
2.
Musculoskeletal Health in Europe – Summary Report (www.eumusc.net). .
3.
Śliwczyński A, Kruszewski R, Binkowski J i wsp. Finansowanie leczenia lekami biologicznymi chorych na reumatoidalne i młodzieńcze idiopatyczne zapalenie stawów w ramach programów zdrowotnych NFZ w latach 2004–2008. Reumatologia 2010; 48: 14-24. .
4.
Sokka T, Kautiainen H, Pincus T, et al. Disparities in rheumatoid arthritis disease activity according to gross domestic product in 25 countries in the QUEST-RA database. Ann Rheum Dis 2009; 68: 1666-1672.
5.
Orlewska E, Ancuta I, Anic B, et al. Access to biologic treatment for rheumatoid arthritis in Central and Eastern European (CEE) countries. Med Sci Monit 2011; 17: SR1-SR13. .
6.
Sokka T, Kautiainen H, Pincus T, et al. QUEST-RA Group. Work disability remains a major problem in rheumatoid arthritis in the 2000s: data from 32 countries in the QUEST-RA study. Arthritis Res Ther 2010; 12: R42. .
7.
Bugajska J, Brzosko M, Jędryka-Góral A, et al. PGG-SES-AIMs. Psychological stress in rheumatoid arthritis patients: a comparative Polish-German study: summary of the current conceptualization of the role of stress in rheumatoid arthritis. Autoimmun Rev 2010; 9: 211-215. .
8.
Sokka T, Hetland ML, Mäkinen H, et al. Remission and rheumatoid arthritis: data on patients receiving usual care in twenty-four countries. Arthritis Rheum 2008; 58: 2642-2651.
9.
Sokka T, Toloza S, Cutolo M, et al. Women, men, and rheumatoid arthritis: analyses of disease activity, disease characteristics, and treatments in the QUEST-RA study. Arthritis Res Ther 2009; 11: R7.
10.
Sokka T, Häkkinen A, Kautiainen H, et al.; QUEST-RA Group. Physical inactivity in patients with rheumatoid arthritis: data from twenty-one countries in a cross-sectional, international study. Arthritis Rheum 200815; 59: 42-50.
11.
Naranjo A, Sokka T, Descalzo MA, et al. Cardiovascular disease in patients with rheumatoid arthritis: results from the QUEST-RA study. Arthritis Res Ther 2008; 10:R30.
12.
Żuber Z, Rutkowska-Sak L, Postępski J i wsp. Długoterminowa ocena bezpieczeństwa i skuteczności leczenia biologicznego młodzieńczego idiopatycznego zapalenia stawów – prezentacja polskiego rejestru elektronicznego. Reumatologia 2011; 49: 1015.
13.
Żuber Z, Rutkowska-Sak L, Postępski J, et al. Etanercept treatment in juvenile idiopathic arthritis: the Polish registry. Med Sci Monit 2011; 7: SR35-SR42.
Copyright: © Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie. This is an Open Access journal, all articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (
https://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.